Literature DB >> 29447420

Point: Weighing the Risks and Benefits of Neoadjuvant Therapy in Resectable Pancreatic Cancer. Early, Aggressive Neoadjuvant Therapy Is Appropriate in Selected Patients.

Davendra P S Sohal.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29447420

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  1 in total

1.  Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling.

Authors:  James C Knight; Julia Baguña Torres; Robert Goldin; Michael Mosley; Gemma M Dias; Luisa Contreras Bravo; Veerle Kersemans; P Danny Allen; Somnath Mukherjee; Sean Smart; Bart Cornelissen
Journal:  J Nucl Med       Date:  2019-12-20       Impact factor: 11.082
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.